Data for: Validity of targeted next generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small cell lung cancer: results of a 2 years experience on 1343 samples

Published: 29 August 2018| Version 1 | DOI: 10.17632/4vmd7bxdct.1
helene blons, Marc Barritault, Véronique Giraudet, Catherine Julie, William Digan, Alain Cazier, Jean Pastre, Laure Gibault, Alice Guyard, Bastien Rance, Pierre Laurent-Puig, Elizabeth Fabre, Stéphane Jouveshomme, Anne Tallet, Nicolas Pecuchet, Véronique Duchatelle, Françoise Le Pimpec-Barthes, Antoine Legras, Etienne Giroux Leprieur


1343 NSCLC patients. Molecular diagnosis, CAST vs NGS. Description of molecular alterations (alterations associations, identifications of new actionable targets) using NGS.



Molecular Biology, Lung Cancer